With 9.6 million shares changed hands, the volume of the stock remained lighter than its average volume of 12.97 million shares. The 52-week range on GERN shows that it touched its highest point at $5.34 and its lowest point at $1.17 during that stretch. It currently has a 1-year price target of $3.69. Beta for the stock currently stands at 0.68.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GERN was up-trending over the past week, with a rise of 5.26%, but this was up by 22.14% over a month. Three-month performance dropped to -7.51% while six-month performance fell -59.49%. The stock lost -59.90% in the past year, while it has lost -54.80% so far this year. A look at the trailing 12-month EPS for GERN yields -0.21 with Next year EPS estimates of -0.04. For the next quarter, that number is -0.03. This implies an EPS growth rate of 52.83% for this year and 65.65% for next year.
Float and Shares Shorts:
At present, 636.92 million GERN shares are outstanding with a float of 603.40 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GERN since 5 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.11103 being high and -$0.3028 being low. For GERN, this leads to a yearly average estimate of -$0.25233.
